Histiocytosis in Injecting Drug Users
- Conditions
- Histiocytosis
- Registration Number
- NCT06573671
- Lead Sponsor
- Tampere University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Enrolling by invitation
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Inclusion Criteria:<br><br> - All identified adult patients in our records with a history of injecting drug use by<br> dissolving tablets containing polyvinylpyrrolidone and (suspected) PVP-histiocytosis<br><br>Exclusion Criteria:<br><br> - Other histiocytosis diagnosed by tissue samples and clinical information
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational [Patient Registry]
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of disease manifestations
- Secondary Outcome Measures
Name Time Method Frequency of elevated chitotriosidase activity;Mortality;Microscopic fluorescence positive tissue;X-ray spectromicroscopy;Pyrolysis mass spectrometry;Transcriptomics analysis